{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T17:57:40Z","timestamp":1779213460477,"version":"3.51.4"},"reference-count":15,"publisher":"Japanese Society of Internal Medicine","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2018,12,15]]},"DOI":"10.2169\/internalmedicine.1195-18","type":"journal-article","created":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T18:49:13Z","timestamp":1533840553000},"page":"3625-3629","source":"Crossref","is-referenced-by-count":15,"title":["Improvement of &lt;i&gt;Mycobacterium abscessus&lt;\/i&gt; Pulmonary Disease after Nivolumab Administration in a Patient with Advanced Non-small Cell Lung Cancer"],"prefix":"10.2169","volume":"57","author":[{"given":"Seigo","family":"Ishii","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Kinki-chuo Chest Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Tamiya","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Kinki-chuo Chest Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiko","family":"Taniguchi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Kinki-chuo Chest Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsunehiro","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Kinki-chuo Chest Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Kinki-chuo Chest Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun-ichi","family":"Isa","sequence":"additional","affiliation":[{"name":"Department of Thoracic Oncology, Kinki-chuo Chest Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunari","family":"Tsuyuguchi","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Kinki-chuo Chest Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuhiro","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Kinki-chuo Chest Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Atagi","sequence":"additional","affiliation":[{"name":"Department of Thoracic Oncology, Kinki-chuo Chest Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Sakatani M. The non-tuberculous mycobacteriosis. Kekkaku 80: 25-30, 2005 (in Japanese, Abstract in English)."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Winthrop KL, McNelley E, Kendall B, et al. Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease. Am J Respir Crit Care Med 182: 977-982, 2010.","DOI":"10.1164\/rccm.201003-0503OC"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Thomson RM. Changing epidemiology of pulmonary nontuberculous mycobacteria infections. Emerg Infect Dis 16: 1576-1583, 2010.","DOI":"10.3201\/eid1610.091201"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175: 367-416, 2017.","DOI":"10.1164\/rccm.200604-571ST"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Prevots DR, Shaw PA, Strickland D, et al. Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am J Respir Crit Care Med 182: 970-976, 2010.","DOI":"10.1164\/rccm.201002-0310OC"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Namkoong H, Kurashima A, Morimoto K, et al. Epidemiology of pulmonary nontuberculous mycobacterial disease, Japan (1). Emerg Infect Dis 22: 1116-1117, 2016.","DOI":"10.3201\/eid2206.151086"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Nakahama K, Tamiya A, Taniguchi Y, et al. Severe acute interstitial lung disease after nivolumab in three non-small cell lung cancer patients with imaging findings of airway obstruction adjacent to lung tumors. J Infect Chemother 23: 826-829, 2017.","DOI":"10.1016\/j.jiac.2017.07.006"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Medical Section of the American Lung Association. Am J Respir Crit Care Med 156: S1-25, 1997.","DOI":"10.1164\/ajrccm.156.2.atsstatement"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175: 367-416, 2007.","DOI":"10.1164\/rccm.200604-571ST"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Lee MR, Sheng WH, Hung CC, Yu CJ, Lee LN, Hsueh PR. <i>Mycobacterium abscessus<\/i> complex infections in humans. Emerg Infect Dis 21: 1638-1646, 2015.","DOI":"10.3201\/2109.141634"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Koh WJ, Jeon K, Lee NY, et al. Clinical significance of differentiation of <i>Mycobacterium massiliense<\/i> from <i>Mycobacterium abscessus<\/i>. Am J Respir Crit Care Med 183: 405-410, 2011.","DOI":"10.1164\/rccm.201003-0395OC"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Shu CC, Wang JY, Wu MF, et al. Attenuation of lymphocyte immune responses during <i>Mycobacterium avium<\/i> complex-induced lung disease due to increasing expression of programmed death-1 on lymphocytes. Sci Rep 7: 42004, 2017.","DOI":"10.1038\/srep42004"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Reungwetwattana T, Adjei AA. Anti-PD-1 antibody treatment and the development of acute pulmonary tuberculosis. J Thorac Oncol 11: 2048-2050, 2016.","DOI":"10.1016\/j.jtho.2016.10.008"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Tsuji T, Tsuyuguchi K, Tachibana K, et al. Analysis of the impact of lung cancer treatment on nontuberculous mycobacterial lung diseases. Respir Investig 55: 45-50, 2017.","DOI":"10.1016\/j.resinv.2016.08.002"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Fujita K, Terashima T, Mio T. Anti-PD1 antibody treatment and the development of acute pulmonary tuberculosis. J Thorac Oncol 11: 2238-2240, 2016.","DOI":"10.1016\/j.jtho.2016.07.006"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/24\/57_1195-18\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T22:53:24Z","timestamp":1571698404000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/24\/57_1195-18\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,15]]},"references-count":15,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.1195-18","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,15]]}}}